ZNF543

gene
On this page

Also known as DKFZp434H055

Summary

ZNF543 (zinc finger protein 543, HGNC:25281) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 543 (Q08ER8). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 125919 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 133 total
  • MANE Select transcript: NM_213598

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25281
Approved symbolZNF543
Namezinc finger protein 543
Location19q13.43
Locus typegene with protein product
StatusApproved
AliasesDKFZp434H055
Ensembl geneENSG00000178229
Ensembl biotypeprotein_coding
OMIM616847
Entrez125919

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000321545, ENST00000869765

RefSeq mRNA: 1 — MANE Select: NM_213598 NM_213598

CCDS: CCDS33130

Canonical transcript exons

ENST00000321545 — 4 exons

ExonStartEnd
ENSE000012232825732663357326728
ENSE000013177865732770457330770
ENSE000014155305732047257320871
ENSE000024372125732368257323808

Expression profiles

Bgee: expression breadth ubiquitous, 133 present calls, max score 83.20.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.2629 / max 57.2208, expressed in 1707 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1777666.10631705
1777670.156672

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.20gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099182.75gold quality
cortical plateUBERON:000534376.08gold quality
ventricular zoneUBERON:000305375.78gold quality
adrenal tissueUBERON:001830375.05gold quality
ganglionic eminenceUBERON:000402374.70gold quality
calcaneal tendonUBERON:000370173.57gold quality
skeletal muscle tissueUBERON:000113473.22gold quality
corpus callosumUBERON:000233672.04gold quality
stromal cell of endometriumCL:000225571.80gold quality
islet of LangerhansUBERON:000000671.67gold quality
muscle tissueUBERON:000238571.23gold quality
tonsilUBERON:000237269.43gold quality
placentaUBERON:000198769.32gold quality
smooth muscle tissueUBERON:000113568.61gold quality
muscle of legUBERON:000138368.50gold quality
lymph nodeUBERON:000002968.36gold quality
gastrocnemiusUBERON:000138868.15gold quality
endometriumUBERON:000129568.07gold quality
hindlimb stylopod muscleUBERON:000425268.07gold quality
bone marrow cellCL:000209267.94silver quality
urinary bladderUBERON:000125567.69gold quality
ovaryUBERON:000099267.21gold quality
left ovaryUBERON:000211966.81gold quality
adrenal glandUBERON:000236966.41gold quality
bone marrowUBERON:000237166.35gold quality
skin of legUBERON:000151166.23gold quality
zone of skinUBERON:000001466.03gold quality
esophagus mucosaUBERON:000246965.79gold quality
right ovaryUBERON:000211865.54gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no4.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

86 targeting ZNF543, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-7110-3P100.0073.182486
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-340-5P100.0072.504437
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-4682100.0068.891258
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-511-3P99.9968.851467
HSA-MIR-453199.9969.703181
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-450099.9972.722367
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-1213699.9872.815713
HSA-MIR-1236-3P99.9468.041695
HSA-MIR-3682-5P99.9367.971163
HSA-MIR-338-5P99.9272.342951
HSA-MIR-145-5P99.9271.131836
HSA-MIR-5195-3P99.9270.921877
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-806399.9169.763146
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-430299.8967.941187
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-5582-3P99.8672.484221
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-548AZ-5P99.8369.943230
HSA-MIR-548T-5P99.8369.913220

Literature-anchored findings (GeneRIF, showing 2)

  • Data indicate 3 variants in 3 novel genes myc target 1 protein (MYCT1), caspase recruitment domain family member 8 (CARD8) and zinc finger protein 543 (ZNF543), associated with familial IgA nephropathy (IgAN). (PMID:26095808)
  • CRISPR/Cas9-Mediated Disruption of ZNF543 Gene: An Approach Toward Discovering Its Relation to TRIM28 Gene in Parkinson’s Disease. (PMID:35467255)

Cross-species orthologs

0 orthologs

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)

Protein

Protein identifiers

Zinc finger protein 543Q08ER8 (reviewed: Q08ER8)

All UniProt accessions (1): Q08ER8

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (1): NP_998763* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (24 total): zinc finger region 13, sequence variant 6, chain 1, domain 1, region of interest 1, compositionally biased region 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q08ER8-F169.720.18

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 41 (showing top): GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, ZNF10_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR340_5P, MIR6809_3P, MIR338_5P, MIR7110_3P, MIR494_3P, MIR4672, MIR4319, MIR5195_3P

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
double-stranded DNA binding1
sequence-specific DNA binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

368 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF543GPATCH2LQ9NWQ4505
ZNF543ARMCX5Q6P1M9480
ZNF543OR4K2Q8NGD2480
ZNF543OR7G3Q8NG95416
ZNF543SVOPLQ8N434399
ZNF543A8MYK1A8MYK1375
ZNF543MRPL23Q16540359
ZNF543GPR174Q9BXC1325
ZNF543MYCT1Q8N699311
ZNF543HIF1ANQ9NWT6257
ZNF543DEFA4P12838254
ZNF543PTBP3O95758247
ZNF543RPL23AP29316243
ZNF543RAET1EQ8TD07241
ZNF543SGPL1O95470231

IntAct

13 interactions, top by confidence:

ABTypeScore
KRTAP10-7ZNF543psi-mi:“MI:0915”(physical association)0.560
MCCZNF543psi-mi:“MI:0915”(physical association)0.560
KRTAP10-6ZNF543psi-mi:“MI:0915”(physical association)0.560
TRIM28ZNF320psi-mi:“MI:0914”(association)0.530
ZNF543IPO8psi-mi:“MI:0914”(association)0.350
ZNF543TRIM24psi-mi:“MI:0914”(association)0.350
ZNF543MCCpsi-mi:“MI:0915”(physical association)0.000
ZNF543KRTAP10-6psi-mi:“MI:0915”(physical association)0.000

BioGRID (22): KRTAP10-7 (Two-hybrid), ZNF543 (Affinity Capture-RNA), ZNF543 (Two-hybrid), KRTAP10-6 (Two-hybrid), ZC3H18 (Affinity Capture-MS), TRIM39 (Affinity Capture-MS), NKTR (Affinity Capture-MS), ZNF445 (Affinity Capture-MS), CENPB (Affinity Capture-MS), UBTF (Affinity Capture-MS), JPH1 (Affinity Capture-MS), ZNF708 (Affinity Capture-MS), FRMD6 (Affinity Capture-MS), KBTBD7 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS)

ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4

Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

133 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance119
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

387 predictions. Top by Δscore:

VariantEffectΔscore
19:57323672:A:AGacceptor_gain1.0000
19:57323673:A:Gacceptor_gain1.0000
19:57323678:CCA:Cacceptor_loss1.0000
19:57323679:CAGG:Cacceptor_loss1.0000
19:57323680:A:AGacceptor_gain1.0000
19:57323680:AG:Aacceptor_gain1.0000
19:57323680:AGGT:Aacceptor_gain1.0000
19:57323681:G:Aacceptor_loss1.0000
19:57323681:G:GAacceptor_gain1.0000
19:57323681:GG:Gacceptor_gain1.0000
19:57323681:GGT:Gacceptor_gain1.0000
19:57323681:GGTG:Gacceptor_gain1.0000
19:57323681:GGTGT:Gacceptor_gain1.0000
19:57323769:G:GTdonor_gain1.0000
19:57323804:TCTGG:Tdonor_gain1.0000
19:57323805:CTGG:Cdonor_gain1.0000
19:57323806:TGG:Tdonor_gain1.0000
19:57323807:GG:Gdonor_gain1.0000
19:57323807:GGG:Gdonor_gain1.0000
19:57323808:GG:Gdonor_gain1.0000
19:57323809:G:GGdonor_gain1.0000
19:57326617:T:TAacceptor_gain1.0000
19:57326625:A:AGacceptor_gain1.0000
19:57326625:AT:Aacceptor_gain1.0000
19:57326626:T:Gacceptor_gain1.0000
19:57326626:T:TAacceptor_gain1.0000
19:57326629:A:AGacceptor_gain1.0000
19:57326629:ACAG:Aacceptor_gain1.0000
19:57326630:C:Gacceptor_gain1.0000
19:57326631:A:ACacceptor_loss1.0000

AlphaMissense

3984 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:57328840:T:CF460L0.997
19:57328842:T:AF460L0.997
19:57328842:T:GF460L0.997
19:57329008:T:CF516L0.997
19:57329010:T:AF516L0.997
19:57329010:T:GF516L0.997
19:57328336:T:CF292L0.996
19:57328338:C:AF292L0.996
19:57328338:C:GF292L0.996
19:57328420:T:CF320L0.996
19:57328422:T:AF320L0.996
19:57328422:T:GF320L0.996
19:57328924:T:CF488L0.996
19:57328926:C:AF488L0.996
19:57328926:C:GF488L0.996
19:57328504:T:CF348L0.995
19:57328506:C:AF348L0.995
19:57328506:C:GF348L0.995
19:57328672:T:CF404L0.995
19:57328674:C:AF404L0.995
19:57328674:C:GF404L0.995
19:57328756:T:CF432L0.995
19:57328758:C:AF432L0.995
19:57328758:C:GF432L0.995
19:57328859:T:CL466P0.995
19:57329092:T:CF544L0.995
19:57329094:T:AF544L0.995
19:57329094:T:GF544L0.995
19:57328252:T:CF264L0.994
19:57328254:T:AF264L0.994

dbSNP variants (sampled 300 via entrez): RS1000102991 (19:57323784 A>G), RS1000267660 (19:57327058 G>A), RS1000293496 (19:57321186 C>T), RS1000324093 (19:57321401 C>T), RS1000432277 (19:57321332 C>T), RS1000613469 (19:57326968 A>C), RS1001167072 (19:57329910 C>T), RS1001207294 (19:57321078 G>A), RS1001490355 (19:57331215 C>T), RS1001675182 (19:57326037 T>C), RS1001720153 (19:57323954 C>T), RS1002147009 (19:57326290 G>A,T), RS1002370782 (19:57331010 C>T), RS1002854714 (19:57320112 T>C), RS1002908478 (19:57320311 G>C,T)

Disease associations

OMIM: gene MIM:616847 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
GSK-J4decreases expression1
bisphenol Faffects cotreatment, increases expression1
triphenyl phosphateaffects expression1
arsenitedecreases reaction, affects binding1
di-n-butylphosphoric acidaffects expression1
abrineincreases expression1
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideaffects cotreatment, increases expression1
jinfukangaffects cotreatment, decreases expression1
Resveratrolaffects cotreatment, increases expression1
Air Pollutantsaffects expression, increases abundance1
Cisplatindecreases expression, affects cotreatment1
Dexamethasoneaffects cotreatment, increases expression1
Indomethacinaffects cotreatment, increases expression1
Methotrexateincreases expression1
Methyl Methanesulfonateincreases expression1
Ozoneaffects expression, increases abundance1
Plant Extractsaffects cotreatment, increases expression1
Smokedecreases expression1
Tetrachlorodibenzodioxinincreases expression, affects cotreatment1
Tobacco Smoke Pollutionincreases expression1
Urethaneincreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, increases expression1
Antirheumatic Agentsincreases expression1
Lactic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.